Effect of a Multi Strain Probiotic on the Gut Microbiota

The Effect of a Multi-strain Live Bacteria Supplement on the Gut Microbiota Composition of Healthy Adults: an Open Label Trial

Over recent years there has been a lot of research looking at how the bacteria in our gut affect our health. Changes to gut bacteria has been linked to several diseases. Taking specific live bacteria supplements (sometimes known as 'probiotics'), to change the balance of our gut bacteria to result in a health benefit have been trialled as a treatment option for many diseases in recent years.

Bio-Kult Advanced is a live bacteria Food supplement that contains 14 different bacteria cultures. The effect of Bio-Kult Advanced on gut bacteria is unknown, therefore, the aim

Study Overview

• Status: Completed
• Conditions: Microbial Colonization
• Intervention / Treatment: Other: Fasted breath samples; Other: Daily Diary; Other: Stool sample

Detailed Description

There is rapidly growing interest in the involvement of the microbiome in health. Imbalance in human gut microbiota, 'dysbiosis', has been linked to several diseases. Manipulation of the microbiome, using specific strains of live micro-organisms, that confer a health benefit on the host (probiotics), have therefore become an exploratory treatment option in microbiome-associated diseases in recent years. Numerous studies have shown selected strains of bacteria to show statistically significant and clinically relevant improvement in symptoms, in a number of diseases, including but not limited to infantile colic and atopic dermatitis.

Bio-Kult Advanced (BKA) is a 14 strain live bacteria supplement containing a Minimum 2 billion live microorganisms per capsule (2x109 CFU/capsule), equivalent to 10 billion live microorganisms per gram (1x1010 CFU/gram). A randomised controlled trial of Bio-Kult Advanced in the management of diarrhoea predominant IBS demonstrated significant improvement in gastrointestinal (GI) symptoms and was well tolerated by participants. Another randomised controlled trial of Bio-Kult Advanced, in participants with episodic and chronic migraine sufferers, demonstrated significant improvement in frequency and severity of migraines compared to placebo. This clinical effectiveness across various conditions, suggest that bacterial strains in Bio-Kult could have an effect on the gastrointestinal flora, however data has yet to be collected that explores the effect of Bio-Kult on the microbiome. The aim of this study is to therefore investigate the effect of Bio-Kult Advanced, on the composition of the gut microbiota in healthy adults.

• Study Type: Interventional
• Enrollment (Actual): 48
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United Kingdom
  • Manchester, United Kingdom, M2 4NG
    • The Functional Gut Clinic

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 40 years (ADULT)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Adult males and females (50:50) between 18 to 40 years old
• No significant medical diagnosis (healthy individuals)
• Not on regular prescription medicines
• No selective/restricted diets (e.g. vegan, low FODMAP)
• Body Mass Index of 18.50-29.99 kg/m2
• Participant able to understand the participant information sheet in English and provide informed consent

Exclusion Criteria:

• Diagnosis of any medical condition, except for visual impairment and other conditions to clinicians discretion
• Prior abdominal surgery (e.g. appendectomy, bariatric surgery )

• Migraine as based on migraine definition by ICHD 2019:

  • A minimum of five attacks (in absolute terms) fulfilling criteria:

    • Duration 4 - 72 hours
    • At least two of the following:
• unilateral location
• pulsating character
• moderate or severe pain intensity
• aggravation by routine physical activity
• Presence of nausea/vomiting OR photophobia/phonophobia during headache

• Ongoing therapy with medication known to affect the gut microbiome:

  • Antibiotics used in the last 8 weeks
  • Proton pump inhibitors used in the last 8 weeks
  • Antidepressants in the last 8 weeks
  • Regular use of laxatives or anti-diarrheal medications
• Alcohol consumption >14 units per week
• Pregnancy or breastfeeding
• Vegan and other selective diets, use of diet replacements (e.g. Huel)
• Regular consumption of probiotics, prebiotics, fibre supplements or any use of probiotics in 2 months prior enrolment
• Unwillingness to exclude other probiotic products from diet during the study period

Study Plan

How is the study designed?

Design Details

• Primary Purpose: BASIC_SCIENCE
• Allocation: NA
• Interventional Model: SINGLE_GROUP
• Masking: NONE

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
EXPERIMENTAL: BioKult Advanced; This is a single arm study, all participants will take Bio-kult Advanced for 56 days (+/- 2days). Participants will be required to take 4 capsules daily.	Other: Fasted breath samples; Participants will provide fasted breath samples pre and post Bio-Kult Advanced.; Other: Daily Diary; Monitoring stool form, consistency and frequency on a daily basis.; Other: Stool sample; Participants will provide stool sample pre and post Bio-kult Advanced.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Stool sample comparison	Comparison between samples at different taxonomical levels (phylum, family, genus and species) will be performed for the identification of specific bacteria in samples of interest. Accumulative bar charts will be provided for rapid inspection. PCA and clustering will be conducted. Biodiversity Index (Shannon, Simpson, Gini-Simpson or Berger-Parker) will be calculated. Biostatistics will be done in order to detect biomarkers between timepoints of the study.	56 days

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Fasting breath samples	Mean change in fasted breath hydrogen and methane, will be determined from baseline to end of study. Mean fasted hydrogen and mean fasted methane will be calculated independently of one each other. Breath hydrogen and breath methane will be measured in units of parts per million (ppm). Statistical significance will be determined using a paired t-test (p<0.05).	56 days
Bowel habit	Mean difference in stool frequency and consistency from baseline and end of study will be determined using a paired t-test, to determine significance (p<0.05).	56 days

Collaborators and Investigators

• Sponsor: The Functional Gut Clinic
• Collaborators: ADM Protexin

Study record dates

Study Major Dates

• Study Start (ACTUAL): November 1, 2019
• Primary Completion (ACTUAL): February 12, 2021
• Study Completion (ACTUAL): February 12, 2021

Study Registration Dates

• First Submitted: September 4, 2020
• First Submitted That Met QC Criteria: September 14, 2020
• First Posted (ACTUAL): September 18, 2020

Study Record Updates

• Last Update Posted (ACTUAL): February 16, 2021
• Last Update Submitted That Met QC Criteria: February 15, 2021
• Last Verified: February 1, 2021

More Information

Terms related to this study

• Keywords: Microbiome; Probiotics; Gastrointestinal
• Additional Relevant MeSH Terms: Pathologic Processes; Disease Attributes; Infections; Communicable Diseases
• Other Study ID Numbers: FGC-19-003

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No